MAMMOMAT B.brilliant with Tomosynthesis Option

Buyer-fit notes

MAMMOMAT B.brilliant with Tomosynthesis Option is best reviewed for Mammography/DBT Breast teams evaluating breast imaging tools with FDA source traceability.

Not ideal for buyers who need public price benchmarks before vendor contact or teams requiring confirmed deployment details before shortlist review.

FDA and evidence source ledger

• P140011/S008 FDA source
• FDA AI-enabled medical devices list

Clinical use

Computer-aided detection/diagnosis